AXIM Biotechnologies, Inc. (AXIM)
USD 0.01
(13.64%)
USD 0.01
(13.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.03 Million | -2.04 Million | -2.48 Million | -3.21 Million | -5.02 Million | -4.84 Million |
| Net Income | -8.05 Million | -6.24 Million | -16.03 Million | -6.4 Million | -6.44 Million | -6.75 Million |
| Depreciation & Amortization | 427.01 Thousand | 426.12 Thousand | 2.11 Million | 16 Thousand | 6514.00 | 12.83 Thousand |
| Deferred income taxes | -769.03 Thousand | - | 7.54 Million | -78.25 Thousand | -382.02 Thousand | 139.53 Thousand |
| Stock-based compensation | 197.72 Thousand | 1.1 Million | 1.14 Million | 2.31 Million | 1.83 Million | 911.34 Thousand |
| Change in working capital | 1.29 Million | 1.03 Million | -28.18 Thousand | 485.77 Thousand | -231.48 Thousand | -218.44 Thousand |
| Other non-cash items | 5.88 Million | 1.62 Million | 2.76 Million | 458.72 Thousand | 199.4 Thousand | 1.06 Million |
| Investing Cash Flow | - | -8710.00 | -50.49 Thousand | 9980.00 | 348.18 Thousand | - |
| Investments in PPE | - | -8710.00 | -50.49 Thousand | -97.32 Thousand | - | - |
| Acquisitions | - | - | - | 79.81 Thousand | -27.49 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 375.67 Thousand | - |
| Other Investing Activities | - | -8710.00 | -10 Thousand | 27.49 Thousand | -27.49 Thousand | - |
| Financing Cash Flow | 1.13 Million | 1.64 Million | 2.53 Million | 3.15 Million | 3.37 Million | 4.59 Million |
| Debt repayment | -675 Thousand | -8200.00 | -120 Thousand | -92.86 Thousand | -86.41 Thousand | -1.96 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 152.88 Thousand | 455 Thousand | 25 Billion | - | 900 Thousand | 600 Thousand |
| Common Stock Issuance | 491.45 Thousand | 1.74 Million | 1.63 Million | 3.3 Million | 3.46 Million | 4.36 Million |
| Other Financing Activities | -26.78 Thousand | 1.65 Million | 1.01 Million | -65 Thousand | -78.91 Thousand | 2.77 Million |
| Accounts receivables | - | 1701.00 | -1026.00 | -675.00 | -315.84 Thousand | - |
| Accounts payables | 769.03 Thousand | 659.4 Thousand | 277.5 Billion | 532.24 Thousand | 673.52 Thousand | -116.33 Thousand |
| Inventory | - | 20.08 Thousand | -20.08 Thousand | 675.00 | -478.01 Thousand | -1032.00 |
| Other working capital | 523.25 Thousand | 358.22 Thousand | -277.5 Billion | -46.47 Thousand | -111.14 Thousand | -101.06 Thousand |
| Cash at beginning of period | 47.28 Thousand | 452.96 Thousand | 457.18 Thousand | 511.63 Thousand | 1.8 Million | 2.05 Million |
| Cash at end of period | 156.45 Thousand | 47.28 Thousand | 452.96 Thousand | 457.18 Thousand | 511.63 Thousand | 1.8 Million |
| Capital Expenditure | - | -8710.00 | -50.49 Thousand | -97.32 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 109.17 Thousand | -405.68 Thousand | -4218.00 | -54.44 Thousand | -1.29 Million | -252.21 Thousand |
| Free Cash Flow | -1.03 Million | -2.05 Million | -2.53 Million | -3.31 Million | -5.02 Million | -4.84 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.26 Million | -292.29 Thousand | -8.05 Million | -1.9 Million | 328.47 Thousand | -3.72 Million |
| Depreciation & Amortization | 108.12 Thousand | 108 Thousand | 427.01 Thousand | 106.75 Thousand | 106.75 Thousand | 106.75 Thousand |
| Deferred income taxes | - | - | -769.03 Thousand | -66.34 Thousand | -1.03 Million | 4.26 Million |
| Stock-based compensation | 9613.00 | 9613.00 | 197.72 Thousand | 34.08 Thousand | 38.41 Thousand | 21.4 Thousand |
| Change in working capital | 278.54 Thousand | -1.09 Million | 1.29 Million | 687.68 Thousand | 244.04 Thousand | -12.51 Thousand |
| Other non-cash items | 1.64 Million | 1.49 Million | 5.88 Million | 1.15 Million | 49.3 Thousand | -1.3 Million |
| Investing Cash Flow | - | -2839.00 | - | - | - | - |
| Investments in PPE | 2.00 | -2839.00 | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -2839.00 | - | - | - | - |
| Financing Cash Flow | 170.87 Thousand | 1.01 Million | 1.13 Million | 113.68 Thousand | 190.22 Thousand | 687.55 Thousand |
| Debt repayment | -100 Thousand | -100 Thousand | -675 Thousand | -100 Thousand | - | -575 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -743.68 Thousand | - | 152.88 Thousand | 152.88 Thousand | - | - |
| Common Stock Issuance | 70.87 Thousand | 910.15 Thousand | 491.45 Thousand | 13.68 Thousand | 190.22 Thousand | 112.55 Thousand |
| Other Financing Activities | - | 630.15 Thousand | -26.78 Thousand | 13.68 Thousand | 190.22 Thousand | 687.55 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 188.07 Thousand | -1.06 Million | 769.03 Thousand | 181.25 Thousand | 236.6 Thousand | 131.52 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 90.47 Thousand | -20.47 Thousand | 523.25 Thousand | 506.42 Thousand | 7439.00 | -144.04 Thousand |
| Cash at beginning of period | 96.71 Thousand | 156.45 Thousand | 47.28 Thousand | 23.22 Thousand | 97.49 Thousand | 53.54 Thousand |
| Cash at end of period | 6044.00 | 96.71 Thousand | 156.45 Thousand | 156.45 Thousand | 23.22 Thousand | 97.49 Thousand |
| Capital Expenditure | 2.00 | -2839.00 | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -90.66 Thousand | -59.74 Thousand | 109.17 Thousand | 133.23 Thousand | -74.27 Thousand | 43.95 Thousand |
| Free Cash Flow | -261.54 Thousand | -1.06 Million | -1.03 Million | 19.55 Thousand | -264.5 Thousand | -643.59 Thousand |
6034
ALLA
4891
3292
2734
002096